(Q40440931)

20 September 2017

1 reference

title

Lipid risk factors and the regression of atherosclerosis (English)

1 reference

20 September 2017

1 reference

A. M. Gotto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604793

9 June 2024

language of work or name

English

0 references

publication date

1 July 1995

1 reference

20 September 2017

13 July 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7604793

full work available at URL

9 June 2024

https://api.elsevier.com/content/article/PII:S0002914905800098?httpAccept=text/xml

1 reference

10.1016/S0002-9149(05)80009-8

DOI

https://api.crossref.org/works/10.1016/S0002-9149(05)80009-8

https://api.elsevier.com/content/article/PII:S0002914905800098?httpAccept=text/plain

9 June 2024

1 reference

10.1016/S0002-9149(05)80009-8

DOI

https://api.crossref.org/works/10.1016/S0002-9149(05)80009-8

American Journal of Cardiology

9 June 2024

published in

1 reference

20 September 2017

volume

76

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

3A-7A

1 reference

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Pravastatin, lipids, and major coronary events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Baseline characteristics of subjects in the Lipoprotein and Coronary Atherosclerosis Study (LCAS) with fluvastatin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Endothelial dysfunction and dyslipidemia: possible effects of lipid lowering and lipid modifying therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980009-8

10.1016/S0002-9149(05)80009-8

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference